Analytica Bio Energy Corp Stock EBITDA
Analytica Bio Energy Corp fundamentals help investors to digest information that contributes to Analytica Bio's financial success or failures. It also enables traders to predict the movement of Analytica Stock. The fundamental analysis module provides a way to measure Analytica Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Analytica Bio stock.
Analytica |
Analytica Bio Energy Corp Company EBITDA Analysis
Analytica Bio's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Analytica Bio EBITDA | (95.25 K) |
Most of Analytica Bio's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Analytica Bio Energy Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Analytica Bio Energy Corp reported earnings before interest,tax, depreciation and amortization of (95,250). This is much lower than that of the sector and significantly lower than that of the EBITDA industry. The ebitda for all United States stocks is notably higher than that of the company.
Analytica EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Analytica Bio's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Analytica Bio could also be used in its relative valuation, which is a method of valuing Analytica Bio by comparing valuation metrics of similar companies.Analytica Bio is currently under evaluation in ebitda category among its peers.
Analytica Fundamentals
| Return On Equity | -16.3 | |||
| Return On Asset | -195.14 | |||
| Profit Margin | 311.56 % | |||
| Operating Margin | (49.59) % | |||
| Current Valuation | 536.46 K | |||
| Shares Outstanding | 29.18 M | |||
| Price To Earning | 0.35 X | |||
| Price To Sales | 1.15 X | |||
| Revenue | 202.5 K | |||
| Gross Profit | 62.91 K | |||
| EBITDA | (95.25 K) | |||
| Net Income | 630.92 K | |||
| Cash And Equivalents | 13.74 K | |||
| Total Debt | 316.75 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 0.31 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | 138.73 K | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 3.32 | |||
| Market Capitalization | 233.44 K | |||
| Total Asset | 400 K | |||
| Retained Earnings | (4.68 M) | |||
| Working Capital | (556 K) | |||
| Current Asset | 249 K | |||
| Current Liabilities | 805 K | |||
| Z Score | -16.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Analytica Stock
If you are still planning to invest in Analytica Bio Energy check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Analytica Bio's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |